Bio-Rad Laboratories (BIO) Shares Outstanding (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported Shares Outstanding (Entity) for 18 consecutive years, with $26.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) fell 1.2% year-over-year to $26.7 million in Q2 2026; TTM through Jun 2026 was $26.7 million, a 1.2% decrease from a year earlier, with the FY2025 full-year figure at $27.0 million, down 3.66% from the prior year.
• Shares Outstanding (Entity) was $26.7 million for Q2 2026 at Bio-Rad Laboratories, roughly flat from $26.8 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $29.9 million in Q1 2022 and troughed at $26.7 million in Q2 2026.
• A 5-year average of $28.3 million and a median of $28.4 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) advanced 0.6% in 2022 and declined 4.6% in 2025, its largest moves.
• Over 5 years, Shares Outstanding (Entity) stood at $29.6 million in 2022, then decreased by 3.64% to $28.5 million in 2023, then fell by 1.76% to $28.0 million in 2024, then declined by 3.66% to $27.0 million in 2025, then retreated by 0.94% to $26.7 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $26.7 million (Q2 2026), $26.8 million (Q1 2026), and $27.0 million (Q4 2025), per Business Quant data.